CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 155 filers reported holding CHINOOK THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $655 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 14,158 | $12,782,000 | 5.70% |
| Samsara BioCapital, LLC | 3,168,388 | $44,738,000 | 5.52% |
| FRAZIER MANAGEMENT LLC | 1,100,000 | $15,532,000 | 1.43% |
| Altium Capital Management LP | 416,567 | $5,882,000 | 1.36% |
| Affinity Asset Advisors, LLC | 200,000 | $2,824,000 | 1.01% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 170,821 | $2,412,000 | 0.64% |
| Vivo Capital, LLC | 872,151 | $12,315,000 | 0.53% |
| EcoR1 Capital, LLC | 931,650 | $13,155,000 | 0.49% |
| ARMISTICE CAPITAL, LLC | 1,236,000 | $17,452,000 | 0.31% |
| Rubric Capital Management LP | 325,863 | $4,601,000 | 0.29% |